Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Specific Focus on Clinical Cardiovascular Pharmacology
The European Heart Journal – Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal reports on the interpretation and integration of new scientific developments to improve the pharmacological treatment of patients with cardiovascular disease.
It publishes original articles on clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.
More knowledge about atrial fibrillation, still we need to learn
Author(s):Agewall S.
04 Aug 2021
Dosage of direct oral anticoagulants during dual and triple antithrombotic therapy: a focus on the net clinical benefit
Author(s):Kazem N, Sulzgruber P, Niessner A.
06 Sep 2021
Call for emergency action to limit global temperature increases, restore biodiversity, and protect healthWealthy nations must do much more, much faster*
Author(s):Atwoli L, Baqui A, Benfield T, et al.
29 Jun 2021
Tocilizumab, blood cells, and mild COVID-19: delayed vascular protection by interleukin blockade?
Author(s):Buryachkovskaya L, Lomakin N, Melkumyants A, et al.
Our mission: To reduce the burden of cardiovascular disease.
Our mission: To reduce the burden of cardiovascular disease.